No Blaming Common Antihypertensives for Pancreatic Cancer, Study Suggests
(MedPage Today) -- Long-time users of dihydropyridine calcium channel blockers (CCBs) were not at disproportionately high risk of pancreatic cancer, according to a large observational cohort study.
Based on primary care records from the U.K. in...
Source: MedPage Today Nephrology - Category: Urology & Nephrology Source Type: news
More News: Calcium | Cancer | Cancer & Oncology | Pancreas | Pancreatic Cancer | Primary Care | Study | Urology & Nephrology